Applications of pharmacogenetics in children with attention-deficit/hyperactivity disorder

Florence Levy School of Psychiatry, University of New South Wales and Prince of Wales Hospital, Sydney, Australia Abstract: This review examines molecular genetic studies shown to be of importance in the etiology of attention-deficit/hyperactivity disorder (ADHD) and contrasts prefrontal versus subc...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας: Levy F (Συγγραφέας)
Μορφή: Βιβλίο
Έκδοση: Dove Medical Press, 2014-11-01T00:00:00Z.
Θέματα:
Διαθέσιμο Online:Connect to this object online.
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_e947b57a06d6422fab1cc33c47eaf666
042 |a dc 
100 1 0 |a Levy F  |e author 
245 0 0 |a Applications of pharmacogenetics in children with attention-deficit/hyperactivity disorder 
260 |b Dove Medical Press,   |c 2014-11-01T00:00:00Z. 
500 |a 1178-7066 
520 |a Florence Levy School of Psychiatry, University of New South Wales and Prince of Wales Hospital, Sydney, Australia Abstract: This review examines molecular genetic studies shown to be of importance in the etiology of attention-deficit/hyperactivity disorder (ADHD) and contrasts prefrontal versus subcortical mechanisms. Although these mechanisms are not completely dissociated, an understanding of prefrontal dopaminergic/noradrenergic versus subcortical D1/D2 receptor mechanisms is useful for studies of diagnosis versus potential adverse effects. Dopamine physiology, dopamine receptor studies, alpha-2 agonist studies, and dopamine transporter and potential new therapies are reviewed. Further understandings of molecular mechanisms involved in etiology versus treatment and adverse effects should help personalize the treatment of ADHD. Keywords: ADHD, dopamine transporter, dopamine receptors, alpha-2 agonists, COMT, stimulant side effects 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Pharmacogenomics and Personalized Medicine, Vol 2014, Iss default, Pp 349-356 (2014) 
787 0 |n http://www.dovepress.com/applications-of-pharmacogenetics-in-children-with-attention-deficithyp-peer-reviewed-article-PGPM 
787 0 |n https://doaj.org/toc/1178-7066 
856 4 1 |u https://doaj.org/article/e947b57a06d6422fab1cc33c47eaf666  |z Connect to this object online.